BuybackMay 5, 2026, 09:36 AM
Novo Nordisk Concludes DKK 3.8B Share Buyback Program
AI Summary
Novo Nordisk announced the conclusion of its DKK 3.8 billion share repurchase program, which ran from February 4, 2026, to May 4, 2026. This program was part of a larger DKK 15 billion repurchase initiative. The company repurchased 14,759,179 B shares at an average price of DKK 257.47, bringing its total treasury shares to 32,148,978 B shares, representing 0.7% of the share capital.
Key Highlights
- Novo Nordisk concluded its DKK 3.8 billion share repurchase program.
- The program ran from February 4, 2026, to May 4, 2026.
- A total of 14,759,179 B shares were repurchased under the program.
- The total transaction value for the concluded program was DKK 3,799,999,990.
- The average purchase price per B share was DKK 257.47.
- Novo Nordisk now holds 32,148,978 B treasury shares, representing 0.7% of its share capital.
- This concluded program is part of a larger DKK 15 billion repurchase initiative.